Aileron Therapeutics Inc.

11/13/2024 | Press release | Distributed by Public on 11/13/2024 06:39

Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.